Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 64.12 +1.47 (+2.35%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viking Thera < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race August 29, 2024 The race to develop the next big obesity treatment is on with leaders Lilly and Novo trying to keep their top slots. Via Investor's Business Daily Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics August 29, 2024 Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC. Via Benzinga Why Viking Therapeutics Stock Got Thrashed on Tuesday August 27, 2024 A monster rival is making aggressive moves in one particular segment. Via The Motley Fool Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug August 27, 2024 The single-dose vials will also increase supply, the drug giant says. Via Investor's Business Daily Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 August 26, 2024 The companies are chasing major innovations. Via The Motley Fool (VKTX) - Analyzing Viking Therapeutics's Short Interest August 21, 2024 Via Benzinga Unpacking the Latest Options Trading Trends in Viking Therapeutics August 20, 2024 Via Benzinga $100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today August 19, 2024 Via Benzinga Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now? August 26, 2024 The new drugs this company is developing could be worth a lot more than the present market value of its stock. Via The Motley Fool Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping? August 20, 2024 Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY. Via Talk Markets Could Viking Therapeutics Become the Next Novo Nordisk? August 17, 2024 Given this biotech's ascent, its odds of becoming a giant are better than most. Via The Motley Fool 3 Promising Biotech Stocks for the Long-Term: August 2024 August 13, 2024 Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session August 12, 2024 Via Benzinga $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today August 05, 2024 Via Benzinga Viking Therapeutics's Options: A Look at What the Big Money is Thinking July 26, 2024 Via Benzinga Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move August 12, 2024 There isn't much to suggest these businesses are actually vulnerable. Via The Motley Fool Here's Why Eli Lilly Stock Dropped 12% Last Month August 08, 2024 News from a competitor gave investors an unwelcome dose of reality. Via The Motley Fool 3 Unstoppable Stocks to Buy in August August 03, 2024 It's not hard to envision how all three of these stocks can deliver exceptional growth. Via The Motley Fool Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now. August 02, 2024 The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth. Via The Motley Fool What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks. August 01, 2024 Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks. Via InvestorPlace 8 Health Care Stocks With Whale Alerts In Today's Session August 01, 2024 Via Benzinga Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening August 01, 2024 Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term. Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session July 30, 2024 Via Benzinga Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma July 30, 2024 Both companies have a clear path to competing successfully in the market. Via The Motley Fool 3 Overlooked Stocks Poised for a Breakout Very Soon July 29, 2024 Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio. Via InvestorPlace Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. July 29, 2024 The Federal Reserve's fight against inflation may soon yield financial benefits. Via The Motley Fool Topics Economy Exposures Interest Rates The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It. July 29, 2024 One preliminary piece of evidence is sending its shares higher. Via The Motley Fool Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia. July 29, 2024 Should you get in on this stock now? Via The Motley Fool ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio? July 28, 2024 Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72% Via Benzinga Is Viking Therapeutics a Millionaire-Maker Stock? July 27, 2024 The stock rose 120% in one trading session earlier this year on positive clinical trial news. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.